Pfizer and Groove Jones Launch Immersive Mixed Reality Experience on Apple Vision Pro to Explain ADC

Pfizer has launched an immersive Vision Pro experience with Apple to educate the public about the development of targeted cancer drugs. The multinational pharmaceutical company partnered with creative technology studio Groove Jones to develop a mixed reality interactive experience for Apple Vision Pro, Apple's first spatial computing device, aimed at patients, healthcare professionals, and the general public, showcasing cutting-edge cancer therapies with a focus on the development mechanism of antibody-drug conjugates (ADCs).

The experience opens with real stories from patients, families, and researchers, accompanied by cinematic visuals and spatial audio rendering, and mentions that about one in three people in the United States will develop cancer in their lifetime. Users are then guided by spatial sound into a simulated Pfizer frontier laboratory environment, where they can browse scientific equipment using Apple Vision Pro's hand-tracking features and participate in an interactive segment called the "ADC Builder." Participants can sequentially select an antibody, a linker, and an anticancer payload, and through this combination, understand how targeted drugs eliminate malignant tumors while protecting healthy tissue.

After completing the molecular construction, users can enter a simulated scene inside human blood vessels and observe, at a microscopic level, how ADC drugs attach to cancer cells and destroy them. Pfizer noted that an innovative therapy typically takes 10 to 15 years of research, development, and clinical trials to move from the laboratory to clinical use. This experience aims to demonstrate the complex mechanisms and development timelines behind breakthrough drugs using spatial computing technology, providing a reference for the application of mixed reality in the life sciences and healthcare sectors.